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Abstract
Early stages of Human Immunodeficiency Virus-1 (HIV-1) infection are associated with local recruitment and activation of
important effectors of innate immunity, i.e. natural killer (NK) cells and dendritic cells (DCs). Immature DCs (iDCs) capture
HIV-1 through specific receptors and can disseminate the infection to lymphoid tissues following their migration, which is
associated to a maturation process. This process is dependent on NK cells, whose role is to keep in check the quality and the
quantity of DCs undergoing maturation. If DC maturation is inappropriate, NK cells will kill them (‘‘editing process’’) at sites
of tissue inflammation, thus optimizing the adaptive immunity. In the context of a viral infection, NK-dependent killing of
infected-DCs is a crucial event required for early elimination of infected target cells. Here, we report that NK-mediated
editing of iDCs is impaired if DCs are infected with HIV-1. We first addressed the question of the mechanisms involved in iDC
editing, and we show that cognate NK-iDC interaction triggers apoptosis via the TNF-related apoptosis-inducing ligand
(TRAIL)-Death Receptor 4 (DR4) pathway and not via the perforin pathway. Nevertheless, once infected with HIV-1, DCHIV
become resistant to NK-induced TRAIL-mediated apoptosis. This resistance occurs despite normal amounts of TRAIL
released by NK cells and comparable DR4 expression on DCHIV. The escape of DCHIV from NK killing is due to the
upregulation of two anti-apoptotic molecules, the cellular-Flice like inhibitory protein (c-FLIP) and the cellular inhibitor of
apoptosis 2 (c-IAP2), induced by NK-DCHIV cognate interaction. High-mobility group box 1 (HMGB1), an alarmin and a key
mediator of NK-DC cross-talk, was found to play a pivotal role in NK-dependent upregulation of c-FLIP and c-IAP2 in DCHIV.
Finally, we demonstrate that restoration of DCHIV susceptibility to NK-induced TRAIL killing can be obtained either by
silencing c-FLIP and c-IAP2 by specific siRNA, or by inhibiting HMGB1 with blocking antibodies or glycyrrhizin, arguing for a
key role of HMGB1 in TRAIL resistance and DCHIV survival. These findings provide evidence for a new strategy developed by
HIV to escape immune attack, they challenge the question of the involvement of HMGB1 in the establishment of viral
reservoirs in DCs, and they identify potential therapeutic targets to eliminate infected DCs.
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Introduction
Dendritic cells (DCs) are crucial for the generation and the
regulation of adaptive immunity. Immature DCs (iDCs) sample the
environment via pattern recognition receptors such as Toll-like
receptors (TLRs), and they undergo a maturation process
characterized by increased expression of HLA class I proteins and
surface molecules (CCR7, CD80, CD86, HLA class II), and
secretion of proinflammatory cytokines and chemokines. Resulting
mature DCs migrate to secondary lymphoid tissues, where they
prime an antigen-specific T cell response [1]. Recently, the fate of
DCs has been found to be extremely dependent on NK cells [2].
After being recruited into inflamed tissues, NK cells can interact
with iDCs, resulting in their activation that, in turn, induce DC
maturation or killing, depending on their respective density [3] [4]
[5]. Thus, one of the major roles of NK cells is to keep in check the
quality and the quantity of DCs undergoing maturation [6]. DC
maturation is dependent on TNF-a produced by activated NK cells
[4], but it also involves the alarmin high-mobility group box 1
protein (HMGB1) released at the synaptic cleft in response to IL-18
produced by DCs [7]. HMGB1 is a highly mobile nuclear protein
that functions to stabilize nucleosome formation, and acts as a
transcription-factor-like protein that regulates the expression of
several genes [8]. HMGB1 is either secreted actively from
inflammatorycells (activated macrophagesand NK cellsinresponse
to inflammatory stimuli), or passively released from necrotic cells to
signal tissue injury. It triggers a cascade of inflammatory responses
through its binding to receptor for advanced glycation end products
(RAGE), TLR2, or TLR4 expressed on monocytes, macrophages
and NK cells [9–11]. As an alarmin, HMGB1 has mobilizing and
activating effects for host defense [12], it facilitates the trafficking of
inflammatory leukocytes, and it is critical for DCs to mature, reach
the lymph nodes and promote polarization of antigen-specific T
cells towards a Th1 phenotype [13–16].
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result in acquisition of NK cytotoxicity against iDCs, which may
represent a mechanism of DC selection required for the control of
downstream adaptive immune response [6]. This editing process is
dependent upon the engagement of NKp30 [17] [18] and
DNAM-1 [19] by ligands expressed on iDC, and the down-
regulation on iDC of HLA-E, the ligand for CD94/NKG2A
inhibitory receptor on NK cells [20]. While NK-dependent killing
of allogeneic DCs in a murine model of skin graft rejection was
reported to involve the perforin pathway [21], the cytotoxic
pathway involved in the killing of syngeneic iDCs has not been
identified yet.
In the context of a viral infection, NK-dependent killing of
infected-DCs is a crucial event required for early elimination of
infected target cells. Indeed, in murine CMV infection, infected
DCs are capable of activating NK cell cytotoxicity in vitro and also
able to enhance NK-cell dependent virus clearance in vivo [22].
HIV has evolved ways to exploit DCs, allowing evasion of antiviral
immunity. Recent reports suggest that NK-DC interactions are
altered in HIV-1-infection. A defect in NK cell lysis of immature
monocyte-derived DCs generated from HIV-1-infected individuals
has been reported [23]. In viremic patients, in vitro interactions
between a CD56
neg/CD16
pos subset of NK cells and autologous
DCs were found markedly impaired, evidenced by abnormalities
in the process of reciprocal NK-DC activation and maturation, as
well as a defect in NK-cell elimination of iDCs [24]. However, the
mechanisms involved in this escape from NK cytotoxicity have not
yet been elucidated.
In this study, we first identified the molecular pathway
implicated in the editing process of non-infected iDCs by NK
cells and found that it did not involve the perforin pathway but
rather the TRAIL/DR4-dependent death receptor pathway. We
then addressed the question of the mechanisms involved in the
resistance of HIV-1-infected DCs (DCHIV) to NK-dependent
killing, and found that it was linked to the dramatic upregulation
of c-IAP2 and c-FLIP in DCHIV, induced by the cognate
interaction with NK cells, and leading to the resistance of DCs
to TRAIL-dependent apoptosis. Furthermore, HMGB1, a key
mediator of NK-DC cross-talk [7,16], was found to play a pivotal
role in the process by upregulating c-IAP2 and c-FLIP in infected
DCs. At present, these data provide evidence for a new strategy
developed by HIV-1 to escape immune attack through the
induction in DCs of a potent anti-apoptotic mechanism leading to
their escape from innate cytotoxicity. They also challenge the
question of the involvement of HMGB1 in the establishment of
viral reservoirs in DCs, and the possible destruction of these
reservoirs by c-IAP2 and c-FLIP antagonists.
Results
Cytotoxic activity of NK cells on autologous primary iDCs
To investigate the impact of NK cells on the fate of DCs, iDCs
were generated from monocytes sorted from healthy donors and
cocultured with autologous purified NK cells (all sorted NK cells
expressed CD56). NK cells were kept either unstimulated (rNK) or
were activated (aNK) with a combination of PHA and IL-2. The
fate of iDCs in 24h NK-DC cocultures was studied by flow
cytometry after exclusion from the analysis of CD56
+ cells (NK
cells). 24 h coculture of aNK cells with autologous iDCs induced
either the survival or apoptosis of iDCs, depending on aNK:DC
ratio, consistent with previous reports [4]. Indeed, at low aNK-DC
ratios (1:5), this interaction induced DC maturation and cytokine
production, as previously reported [4,16], while higher NK:DC
ratios (5:1) induced DC killing by autologous NK cells [4]
(Fig. 1A). FSC/7-AAD dot plots distinguish living (7-AAD
neg
FSC
high) from apoptotic (7-AAD
pos FSC
low) DCs and apoptotic
bodies (7-AAD
neg FSC
low) [25]. Reduced DCs survival combined
with the accumulation of apoptotic bodies was detected at high
aNK:DC ratio (5:1), while normal iDC survival and no accumu-
lation of apoptotic bodies was observed at aNK:DC ratio of 1:5, as
compared with iDCs cultured alone (Fig. 1A). Under the same
conditions, rNK cells had no impact on the fate of iDCs and did
not kill them (Fig. 1A). In order to confirm that apoptotic cells and
bodies were generated from iDCs, two additional approaches were
used. In the first one, the level of apoptosis in gated CD56
+ aNK
cells was compared when cultured alone or in the presence of
iDCs. Figure S1 (panel A) shows that there was no induction of
apoptosis in aNK cells after their cross-talk with iDCs (ratio 5:1),
andnoincreaseofapoptoticbodieseither(notshown).Inthesecond
approach, aNK cells were stained with CFSE prior to their
coculture with iDCs, and apoptosis was analyzed in Carboxyfluor-
escein succinimidyl ester (CFSE)
neg cells, e.g. DCs. Figure S1
(panelB)confirmsthat,at5:1ratio,aNKcellskilliDCs,asshown by
the increased percentages of apoptotic cells (7-AAD
pos FSC
low)a n d
apoptotic bodies (7-AAD
neg FSC
low) in CFSE
neg cells in aNK:DC
cocultures compared to iDCs cultured alone. Live video microscopy
pictures in Fig. 1B show the kinetics of events following the rapid
contact of one NK cell with one DC, leading to an NK cell kiss of
death, inducing immediate plasma membrane blebbling in the DC,
a classical feature of apoptotic death (see the video http://www.
bioimageanalysis.org/plospathogens2010_suppldata). Death trig-
gering of iDCs by aNK cells is a very rapid process, detected a
few seconds after cell contact at the single cell level (Fig. 1B), and
reaching a plateau after 1 hour in bulk cultures, as measured by 7-
AAD staining in 24 h kinetics experiments (Fig. 1C). Since the
editing process of iDCs by NK cells is supposed to keep in check the
quality of DCs undergoing maturation [6], we assumed that DCs
surviving the interaction with aNK cells were mature. Fig. 1D
shows that survival of DCs in aNK:iDC cocultures was associated
with their maturation, as demonstrated by the coexpression of the
Author Summary
Dendritic cells (DCs), the professional antigen presenting
cells, are critical for host immunity by inducing specific
immune responses against a broad variety of pathogens.
Human Immunodeficiency Virus-1 (HIV-1) has evolved ways
to exploit DCs, thereby facilitating viral dissemination and
allowing evasion of antiviral immunity. In particular, infected
DCs may function as cellular reservoirs for HIV-1, thus
contributing to viral persistence in lymphoid tissues. The
mechanisms involved in the constitution of HIV reservoirs in
DCs are poorly understood. In this study, we reveal that DCs
infected with HIV-1 (DCHIV) become resistant to killing by
natural killer (NK) cells, early effectors of innate immunity
involved in the destruction of virus infected cells or cancer
cells.ThisprotectionofDCHIVfromNKcytotoxicityisinduced
through a cross-talk between NK cells and DCHIV,w h i c h
induces the upregulation in DCHIV of two inhibitors of cell
death, i.e. cellular-Flice like inhibitory protein (c-FLIP) and
cellular inhibitor of apoptosis 2 (c-IAP2). The molecule
responsible for the induction of these inhibitors is High-
mobility group box 1 (HMGB1), an alarmin involved in the
functional maturation of DCs. Blocking HMGB1 restores
DCHIV susceptibility toNK cellkilling, arguing for a key role of
HMGB1 in the persistence of DCHIV. These findings provide
evidence of the crucial role of NK-DC cross-talk in promoting
viral persistence, and they identify potential therapeutic
targets to eliminate infected DCs.
NK-DC Crosstalk in HIV Infection
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characteristics were observed in control mature DC0, induced by
48 h stimulation with LPS (Fig. 1D). The expression of two other
maturation markers, DC-SIGN and CD83 was investigated
(Fig. 1E). Surviving iDCs in aNK:DC cocultures showed increased
expression of CD83 and decreased expression of DC-SIGN as
compared to DC cultures alone, confirming their mature stage.
Apoptosis of iDCs induced by aNK cells is not
perforin - dependent
Classically, NK cells kill their targets through the perforin/
granzyme pathway. To determine its possible involvement in NK-
dependent killing of iDCs, intracellular perforin staining was
compared in rNK, aNK, and aNK-iDC cocultures. Perforin was
found mostly expressed in CD56
dim NK cells and activation of NK
cells did not induce marked changes in perforin expression.
Following coculture with iDCs, aNK cells did not express more
perforin (Fig. 2A), suggesting that this cytotoxic pathway was not
used to kill iDCs. This was confirmed by the lack of CD107a
externalization when aNK cells were cocultured with iDCs, while
NK stimulation with PMA/ionomycin induced CD107a expres-
sion (Fig. 2B). These observations were made under conditions
whereby aNK cells were able to kill iDCs, from 1 to 24 hours of
coculture. Furthermore, the addition of an inhibitor of perforin-
mediated lysis, Concanamycin A (CMA), at concentrations
ranging from 50 to 500 nM, was unable to block NK-dependent
killing of iDCs (Fig. 2C). Altogether, these data are not in favor of
the involvement of the perforin pathway in the NK-dependent
editing process of iDCs.
NK cell-dependent editing of iDCs involves the
TRAIL/DR4 pathway
TNF-related apoptosis-inducing ligand (TRAIL) is active in two
forms, either expressed at the cell membrane (mTRAIL), or as a
soluble form secreted in the cell environment (sTRAIL). mTRAIL
expression on CD56
+ aNK cells was found restricted to CD56
bright
NK cells (Fig. 3A). However, following their contact with iDCs,
both CD56
bright and CD56
dim NK cells expressed mTRAIL
suggesting that killing of iDCs was not restricted to CD56
bright cells
(data not shown). sTRAIL was mainly secreted by aNK cells,
including in cocultures of aNK:iDC, under conditions whereby
iDCs were killed by aNK cells (NK:DC ratio of 5:1) (Fig. 3B).
iDCs did not express mTRAIL, whether cultured alone or in the
presence of NK cells (data not shown), and accordingly they did
not release sTRAIL in culture supernatant (Fig. 3B). iDCs were
susceptible to rhsTRAIL, which in turn induced DR4 expression
on these cells (Fig. 3C). 24h kinetic experiments of DC-killing by
aNK cells showed the progressive increase of apoptotic DCs within
DR4
+DCs, arguing for the involvement of DR4 receptor in the
death of iDCs (Fig. 3D). DR5 expression was not induced on
iDCs by aNK cells, ruling out its involvement in the apoptosis
process (Fig. 3E), neither was Fas expressed on iDCs under the
same conditions (Fig. 3E). The involvement of the TRAIL/DR4
pathway in aNK-dependent killing of iDCs was confirmed by the
blocking effect of anti-TRAIL antibodies (1mg/ml) that resulted
in a significant decrease in DR4
+ apoptotic DCs (Fig. 3F).
Moreover, anti-DR4 antibodies abrogated aNK-induced apoptosis
of iDCs, while anti-Fas antibodies had no effect (Fig. 3G).
Collectively, these results indicate that the pathway used by aNK
cells to kill iDCs involves the death ligand TRAIL, whose release
by NK cells induces DR4 receptor on iDCs, followed by their
killing.
HIV-1-infected iDCs are resistant to NK-dependent
TRAIL-mediated killing
To address the question of the impact of HIV-1 on DC’s
susceptibility to NK killing, iDCs were infected with 1ng of p24/
ml of R5-HIV-1BaL, 24 h prior to coculture with aNK cells. HIV-
1-infected iDCs (DCHIV) were found resistant to aNK-induced
cytotoxicity, the proportions of living DCs (FSC
high 7-AAD
low)
being unchanged after cognate interaction with aNK cells
(Fig. 4A). It was also evidenced by the lack of caspase-3 activation
in DCHIV under the same culture conditions (Fig. 4B). Surviving
DCs exhibited a mature phenotype, as shown by the co-expression
of CD86 and HLA-DR on their cell surface (Fig. 4A). DCHIV
resistance to NK killing was dependent on HIV-1 replication in
DCs. Indeed, adding AZT at the initiation of iDCs infection (1ng/
ml of R5-HIV-1BaL), at the concentration of 1mM that completely
inhibited HIV-1 replication in these cells (as shown by the lack of
detection of p24 in culture supernatant), preserved the editing
process (e.g. susceptibility of DCHIV to NK killing) (Fig. 4C).
Thus, productive HIV-1 infection of DCs was required for their
acquired resistance to NK-mediated cytotoxicity (Fig. 4C).
Resistance of DCHIV to NK cell killing was independent of DR4
expression, the frequency of DR4
+ cells being similar in infected
vs. uninfected DCs (Fig. 4D, left panel), and the amount of
sTRAIL released by aNK cells was comparable in NK:DC vs
NK:DCHIV cocultures (Fig. 4D, middle panel). Moreover, DCHIV
were found to be as susceptible as uninfected iDCs to recombinant
sTRAIL (Fig. 4D, right panel). Thus, DCHIV resistance to NK
cytotoxicity was not associated with defective TRAIL release by
NK cells or altered DR4 expression by DCHIV. In order to identify
key molecules involved in the resistance of DCHIV to NK killing,
gene array experiments were performed and differential gene
expression was compared between aNK:DCHIV vs aNK:iDC. The
expression profiles shown in Fig. 4E indicate a decrease in the
expression of some caspase genes (Caspase-2, -6, -7 and -9), or
death-ligand genes (e.g. TNF or FasL) in cocultures of aNK-
iDCHIV,. In parallel, a dramatic upregulation of two anti-apoptotic
genes, c-IAP2 (26.1 fold increase) and c-FLIP (15 fold) was
detected in aNK:DCHIV as compared to aNK:iDC cocultures
(Fig. 4E). The expression of Bcl-2 and Mcl-1 was unchanged,
whether tested in gene array experiments, or by flow cytometry in
DCHIV in the presence or absence of NK cells (data not shown).
Figure 1. aNK cells induce apoptosis of primary immature DCs. (A) iDCs, generated from purified CD14
+ monocytes in the presence of IL-4
and GM-CSF, were co-cultured during 24 h with rNK or aNK at two different NK:DC ratios (1:5 and 5:1). DC survival was determined by flow cytometry
with the 7-AAD assay. Surviving DCs were identified as CD56
neg 7-AAD
neg FSC
high cells. Histograms (left side) show the mean 6 sd of three
independent experiments * p,0.05, and histograms (right side) show the mean 6 sd of experiments performed with cells from 14 healthy donors
** p,0.00001). (B) Kinetics of NK-mediated DC apoptosis observed by live video microscopy. The arrows point out the appearance of blebs in iDCs.
Pictures from one representative out of three experiments are shown. (C) Kinetics of iDC apoptosis, measured as described in (A), cultured alone or in
the presence of aNK cells. Data representative from one out of three independent experiments are shown. (D) Analysis of the maturation stage of
surviving DCs, after 24 h of culture in medium (iDC) or in the presence of aNK cells (ratio 1:5 and 5:1), or induced to mature with LPS (DC0). Mature
cells are identified through the co-detection of surface HLA-DR and CD86. The proportions of double positive cells are indicated. Histograms show
the mean 6 sd of three independent experiments * p,0.05. (E) Surface expression of DC-SIGN and CD83 in surviving DCs cultured as described in
(D). Data are representative of one out of three independent experiments.
doi:10.1371/journal.ppat.1000862.g001
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killing is associated with increased expression of c-FLIP
and c-IAP2
The strong impact of aNK cells on c-IAP2 upregulation in
DCHIV during NK-DC cross-talk is shown in Fig. 5A Intracellular
flow cytometry analysis shows that c-IAP2 is expressed in the
majority of surviving DCs at low levels, whether infected or not by
HIV-1. Cognate interaction of DCHIV with aNK cells induced a
strong up-regulation of c-IAP2 in the great majority of DCHIV
(CD56
neg), whereas it had no effect on uninfected iDCs under the
same conditions (85% vs 8% of c-IAP2
bright cells) (Fig. 5A). HIV-1
infection by itself only slightly increased c-IAP2 expression in iDCs
(11% in DCHIV vs 5% in iDCs of c-IAP2
bright cells). Thus,
resistance of DCHIV to NK killing is associated with the
upregulation of c-IAP2 in these cells. c-IAP2 up-regulation in
DCHIV following their cognate interaction with aNK cells was
confirmed by confocal microscopy (Fig. 5B). DC survival was
strongly dependent upon c-IAP2 expression. Indeed, the knock-
down of c-IAP2 with specific siRNA induced apoptosis of both
uninfected iDCs and DCHIV, in a dose-dependent manner
(Fig. 5C). The expression of another anti-apoptotic molecule
was identified by microarray analysis as being upregulated in
DCHIV following their contact with aNK cells, i.e. c-FLIP
(Fig. 4D). This was confirmed by intracellular flow cytometry
analysis, showing that c-FLIP expression was slightly increased
in DCHIV vs iDCs (13% vs 5%), whereas a strong induction of
Figure 2. aNK-mediated killing of iDCs is independent of the perforin pathway. (A) Analysis of intracellular perforin expression in sorted
primary rNK cells, or aNK cells cultured either alone or in the presence of iDCs for 24 h. Dot plots represent perforin expression in CD56
dim and
CD56
bright NK cells. Histograms show the mean 6 sd of three independent experiments (perforin expression was similar under the three conditions).
(B) Surface CD107a expression in either aNK cells, or aNK cells stimulated by PMA+ionomycin or cocultured with iDCs for 24 h. The proportions of
both CD56
+CD107a
+ and CD56
+CD107a
2 cells are indicated. Histograms show the mean 6 sd of three independent experiments * p,0.05. (C) iDCs
were cultured for 24 h either alone or with aNK cells, in the absence or presence of concanamycin A (CMA), an inhibitor of perforin-based cytotoxic
activity. Surviving DCs, identified as CD56
neg 7-AAD
neg FSC
high cells, were quantified and the percentages indicated in red. Histograms show the mean
6 sd of three independent experiments * p,0.05.
doi:10.1371/journal.ppat.1000862.g002
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PLoS Pathogens | www.plospathogens.org 5 April 2010 | Volume 6 | Issue 4 | e1000862Figure 3. NK cell-dependent editing of iDCs involves the TRAIL/DR4 pathway. (A) Membrane TRAIL (mTRAIL) expression by aNK cells was
analyzed after surface dual staining with anti-CD56 and anti-mTRAIL specific antibodies. The percentage of mTRAIL-expressing aNK cells among
either total CD56
+, or CD56
bright or CD56
dim subsets is shown. Data represent the mean 6 sd of three independent experiments. * p,0.05. (B) Soluble
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(86% of c-FLIP
high in DCHIV vs 21% in iDC) (Fig. 5D). The key
role of c-FLIP on DC resistance to NK killing was confirmed using
a specific inhibitor Bisindolylmalmeimide III (Bis III). Blocking c-
FLIP activity with Bis III added at 25mM in NK-DCHIV cocultures
significantly restored the susceptibility of HIV-1-infected DCs to
NK cytotoxicity, whereas it preserved the survival of iDC or
DCHIV cultured alone (Fig. 5E). The involvement of c-FLIP in
DC survival was confirmed with specific siRNAs. Indeed, the
knock-out of c-FLIP induced apoptosis of iDCs, in a dose-
dependent manner (Fig. 5F). Strikingly, higher siRNA concen-
trations were needed to induce apoptosis in DCHIV as compared
to iDCs (Fig. 5F). Overall these silencing experiments show the
essential role of c-FLIP and c-IAP2 on the survival of primary
DCs, which is consistent with the mechanism proposed for DC
resistance to NK killing.
Pivotal role of HMGB1 in NK-dependent upregulation of
c-IAP2 and c-FLIP in HIV-1-infected DCs
We recently reported that activated NK cells were able to
induce the maturation of HIV-1-infected DCs, at NK-DC ratio of
1:5, but it resulted in a dramatic increase in viral replication and
proviral DNA expression in DCs [16]. This process was mainly
triggered by HMGB1, released by both cell types, as a
consequence of NK-DC cross-talk [7]. Fig. 6A confirms that
both uninfected and HIV-1-infected iDC spontaneously released
high levels of HMGB1 during a 24h culture. Their interaction
with aNK cells at a 5:1 ratio resulted in an enhancement of
HMGB1 production in culture supernatant due to the additive
effect of HMGB1 released by NK cells, as we previously showed
[16]. Analysis of NK-DC conjugates by confocal microscopy
confirmed the expression of HMGB1 both by NK cells and DCs,
and whatever the infected status of DCs (Fig. 6B) [16]. The
possible involvement of HMGB1 in the induction of the resistance
state of DCHIV to NK killing was tested in NK-DC co-cultures in
the presence of either Glycyrrhizin, known to interact specifically
with soluble HMGB1 [26], or anti-HMGB1 neutralizing antibod-
ies. Both inhibitors, added at the initiation of the 24h aNK-
iDCHIV cocultures, restored the susceptibility of HIV-1-infected
DCs to NK cytotoxicity, leading to a significant decrease in
DCHIV survival (Fig. 6C). These inhibitors had no impact on
DCHIV survival in the absence of NK cells. Simultaneous flow
cytometry analysis of c-IAP2 expression revealed that anti-
HMGB1 antibodies abrogated c-IAP2 up-regulation in DCHIV
(Fig. 6D lower panel) and, as a corollary, rHMGB1 was found to
upregulate c-IAP2 in iDCs (Fig. 6D upper panel). Similar
observations were made for c-FLIP. Anti-HMGB1 antibodies
induced a strong decrease in c-FLIP expression in DCHIV
cocultured with aNK cells (Fig. 6E), while rHMGB1 increased
c-FLIP expression in iDC when cocultured with aNK cells
(Fig. 6F). Altogether, these observations argue for a pivotal role of
HMGB1 in the acquired resistance of HIV-1-infected DCs to NK
cytotoxicity, preventing TRAIL-induced apoptosis by upregulat-
ing two potent inhibitors, c-IAP2 and c-FLIP.
In a previous study, we reported that NK:DCHIV cognate
interaction under conditions of DC maturation (ratio 1:5) resulted
in a strong increase in HIV-1 viral replication in DCs (detected at
day 3 after infection), that was mediated by HMGB1 [16]. We
confirmed these observations in the present study, showing that
NK-DCHIV cross-talk under conditions of protection of DCHIV
from TRAIL-induced apoptosis stimulates HIV-1 replication in
DCHIV, measured either as p24 release in culture supernatant of
following intracellular detection of p24 in DCs (data not shown).
Thus, DC escape from NK cytotoxicity contributes to viral
dissemination and persistence.
Discussion
In opposition to the immune sentinel function of DCs to capture
and present processed antigens from pathogens, HIV-1 hijacks
DCs to promote viral dissemination. In a recent study, we reported
that the cross-talk between NK cells and HIV-1-infected DCs,
under conditions of DC maturation, resulted in a dramatic
increase in viral replication and proviral DNA in DCs, and this
process was mainly triggered by HMGB1, a DC maturation factor
produced in NK-DC cocultures [16]. In the present study, we
show for the first time that NK-DC cross-talk, under conditions of
killing of iDC by NK cells, results in a strong resistance of HIV-1
infected DCs to NK cytotoxicity, preventing elimination of
infected DCs and thus contributing to viral dissemination.
HMGB1 was found to be a key factor in DC resistance to NK
killing, inducing the upregulation of c-FLIP and c-IAP2 in infected
DCs, thus preventing TRAIL-dependent NK-mediated cytotoxic-
ity. Therefore, cognate interactions between NK cells and DCs,
required for regulation of innate immunity [6], and found in vivo to
be integral to the activation of effective antiviral immunity [22],
become detrimental to the host in the context of HIV infection.
NK cells have the capacity to spontaneously kill tumor cell lines,
in contrast they do not generally kill non transformed autologous
cells. NK cells were recently shown to play a relevant role in the
process of DC maturation, either by direct DC stimulation or
through killing those DCs that did not properly acquire a mature
phenotype (‘DC editing’) [27] [6] [28]. Killing of autologous
immature DCs was reported to involve NK-p30 [17] and DNAM-
1 [19] and to be confined to NK-cells expressing CD94-NKG2A
inhibitory receptor [20]. While the NK receptors involved in NK-
mediated DC killing have been, at least in part, identified, the
molecular pathway whereby NK cells kill DCs is less understood.
In the present study, we identified the cytotoxicity pathway used
TRAIL (sTRAIL) was quantified by ELISA in 24h cell-free culture supernatants from iDCs (10
6/ml), rNK cells (10
6/ml), aNK cells (10
6/ml), or aNK-iDCs
cocultures at 1:5 (2610
5 NK:10
6 DCs), 1:1 (2610
5 NK: 2610
5 DCs) and 5:1 (10
6 NK: 2610
5 DCs) ratios. The dotted line shows the limit of sTRAIL
detection. Data represent the mean 6 sd of three independent experiments. * p,0.05. (C) iDCs were cultured for 24 hours with increasing
concentrations (1–500 ng/ml) of recombinant human soluble TRAIL (rhs-TRAIL). Cell death was quantified with the 7-AAD assay and surface
expression of DR4 on DCs was analyzed by flow cytometry. Data represent the mean 6 sd of three independent experiments. (D) 24 h kinetics of DR4
expression at the surface of DCs that were cultured alone or with aNK at aNK:iDC ratio of 5:1. Grey and orange histograms indicate the proportions of
dead and living DR4
+DCs respectively, among total DR4
+DCs. Inserted dot plots show that the great majority of 7-AAD
+ DCs are DR4
+ after 24 h of
coculture with aNK cells. Data from one representative out of three experiments are shown. (E) Membrane expression of DR4, DR5 and Fas on iDCs
cultured either alone or with aNK cells for 24 h was detected by flow cytometry. aNK cells were excluded from the analysis by gating on CD56
neg cells.
Dot plots from one representative out of three experiments are shown. (F) The impact of neutralizing anti-TRAIL antibodies on DR4 expression and
killing of iDCs was tested in 24 h aNK-iDC cocultures. The percentage of 7-AAD/DR4 single and double positive populations are indicated in the
quadrants. Dot plots from one out of three experiments are shown. (G) The impact of either anti-DR4 or anti-Fas antibodies on aNK-mediated killing
of iDCs in a 24 h coculture is shown. Early and late apoptotic DCs (gated as CD56
neg) are identified by 7-AAD
low and 7-AAD
high staining, as reported
[25]. Dot plots are representative of one of three independent experiments.
doi:10.1371/journal.ppat.1000862.g003
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PLoS Pathogens | www.plospathogens.org 8 April 2010 | Volume 6 | Issue 4 | e1000862by human NK cells to kill autologous iDCs and found that the
TRAIL/DR4 pathway was used rather than the perforin pathway.
TRAIL is a member of the TNF ligand family that signals
apoptosis via the death domain–containing receptors TRAIL-R1
(DR4) and TRAIL-R2 (DR5). It is primarily expressed as a type II
membrane protein (mTRAIL) and is also secreted in a soluble
form (sTRAIL) only by activated T and NK cells. In the present
study, we found mTRAIL expression confined to CD56
bright cells,
whereas perforin expression was restricted to CD56
dim cells and
independent of NK-cell activation state (in agreement with
previous reports [29]). Activation of NK cells triggered TRAIL
release, and cognate interaction with iDCs induced DR4
expression on a fraction of them, which became susceptible to
TRAIL-mediated apoptosis. iDCs by themselves were not able to
produce TRAIL. Preventing TRAIL-DR4 interaction with
specific blocking antibodies inhibited NK-mediated iDC killing,
while the perforin-based cytotoxicity inhibitor concanamycin A
had no effect. These data are consistent with a previous study
showing that in vivo elimination of iDCs by murine NK cells is
TRAIL-dependent [30]. Surface-bound TRAIL is one of the
effector mechanisms of NK cells in suppression of tumor cell
growth in vivo [31], and it selectively kills virus-infected cells while
leaving uninfected cells intact [32]. We report herein for the first
time that TRAIL is the major effector mechanism of iDC editing
by human NK cells.
The contribution of NK-DC crosstalk to the control of viral
infections is poorly documented. Andoniou et al. demonstrated, in
an in vivo murine model of MCMV infection, that virus-infected
DCs are capable of enhancing NK-cell cytotoxicity and NK cell-
dependent clearance of the virus [22], arguing for a protective role
of innate cell cross-talk. Nevertheless, HIV-1 seems to exploit this
cross-talktoitsown advantage.Indeed, abnormalitieswerereported
in the in vitro interactions between NK cells and autologous DCs
from viremic HIV-1-infected patients, including an impairment in
NK-cell-mediated elimination of iDCs [24]. It has been attributed
to defective NK-cell mediated killing associated to impaired
expression and function of NKp30 and TRAIL by patients’ NK
cells [24]. In the present study, we addressed whether infected DCs
had any role in the impairment of NK cells to kill them. We report
for the first time that HIV-1 infection protects DCs from NK cell
cytotoxicity through a mechanism involving the cognate interaction
between aNK cells and DCHIV, which rescues DCHIV from
TRAIL-mediated killing by upregulating two potent inhibitors of
apoptosis, c-FLIP and c-IAP2. Apoptosis is a tightly regulated cell
process where intracellular proteins c-FLIP [33] and c-IAPs [34,35]
are major players, blocking the death receptor signaling pathway by
preventing caspase-8 activation [36] at the death-inducing signaling
complex (DISC) [37], and inhibiting the effector capsase-3, re-
spectively. Thus, while c-IAP2 and c-FLIP were expressed by all
iDCs, whether infected or not, cognate interaction between aNK
cells and iDCs upregulated the expression of both inhibitors of
apoptosis in HIV-1-infected DCs only, making these cells resistant
to NK killing. From these observations we concluded that c-
IAP2
bright and c-FLIP
bright DCs acquired a state of resistance to
TRAIL-mediated NK cytotoxicity. We also discovered that DCHIV
rescuingprocesswasmediatedbythe alarminHMGB1,essentialfor
the promotion of DC maturation and elicitation of an immune
response [13,38]. HMGB1, detected in the nucleus of sorted
primary NK cells [16] and translocated to the cytoplasm following
theiractivation[16],was alsoexpressedinDCs,whether infected by
HIV-1 or not. HMGB1 was also released by both cells in culture
supernatants, at similar levels in iDCs or DCHIV and in aNK-iDC
or aNK-DCHIV cocultures. In a recent study, it was proposed that
HMGB1 secretion by NK cells is dependent upon IL-18 released by
iDC at the synaptic cleft, inducing DC maturation and protection
from lysis [7]. However, the mechanism involved in DC protection
from NK lysis was unknown, and our study is the first to report a
strong inducer effect of HMGB1 on c-FLIP and c-IAP2 expression
as a survival mechanism. Our observations are compatible with a
recent study reporting in human colon carcinomas a correlation
between increased HMGB1 levels and enhanced amounts of
c-IAP2 [39].
Since DCs are located in the mucosa [1] and thought to be
among the first cells that encounter HIV-1 during sexual
transmission [40] and disseminate the virus in lymphoid organs,
it was important to determine the consequences of aNK-iDCs
interaction on viral replication and persistence. Our previous study
[16] and this one strongly argue for a deleterious role of NK cells,
through HMGB1 release, on HIV-1 control. Indeed, under
conditions of iDC maturation (NK:DC ratio of 1:5) [16] and iDC
killing (NK:DC ratio 5:1) (not shown), aNK-DCHIV interaction led
in a few hours to a significant increase in the frequency of infected
DCs and in the production of viral particles [16]. Furthermore,
under conditions of DC killing, aNK-DCHIV interaction led to the
resistance of infected DCs to NK cytotoxicity. The pivotal role of
HMGB1 in that context is puzzling. It was reported to activate
replication of latent HIV-1 in infected monocytic cell lines [41] but
also in primary infected DCs [16], but in some cases HMGB1 was
found to inhibit viral production by macrophages, either by
increasing the release of CCR5-interacting chemokines
(RANTES, MIP-1a and MIP-1ß) [41] or by another mechanism
to be determined [42]. Nevertheless, our report reveals that
HMGB1 is essential for the survival of infected DCs, promoting
the up-regulation of potent suppressors of apoptosis, c-FLIP and c-
IAP2. Interestingly, the resistance of infected DCs to NK killing
required productive HIV-1 infection, as the addition of AZT at
the time of DC infection preserved their susceptibility to NK
killing. Since specific inhibitors of HMGB1 also allowed
productively infected DCs to be killed by NK cells, these
observations indicate a conjugated effect of both HMGB1 and
Figure 4. HIV-infected iDCs are resistant to NK-mediated killing. (A) iDCs were either uninfected or infected for 24 hours with R5-HIV-1BaL
(1 ng/ml of p24), and further incubated for 24 hours with aNK cells at NK:DC ratio of 5:1. Viability of iDCs was assessed using the 7-AAD assay. Living
DCs are identified as CD56
neg 7-AAD
neg FSC
high. Inserts: the maturation stage of DCs was determined via the dual staining of gated living DCs with
anti-CD86 and -HLA-DR specific antibodies. Dot plots show one representative out of more than ten independent experiments. Histograms show the
mean 6 sd of experiments performed with cells from 10 healthy donors. * p=0.0001. (B) Intracellular active caspase-3 detection by flow cytometry in
iDC and DCHIV cultured alone, or cocultured with aNK cells for 24 hours. Data represent the mean 6 sd of three independent experiments. * p,0.05.
(C) iDCs were infected for 24 hours with R5-HIV-1BaL (1 ng/ml of p24) in the presence or absence of AZT 1mM, and further incubated either alone or
with aNK cells at NK:DC ratio of 1:5. Uninfected iDCs were submitted to the same culture conditions. Viability of iDCs was assessed using the 7-AAD
assay, as detailed for panel A (D) iDCs or DCHIV, cultured either alone or in the presence of aNK cells, were compared for DR4 expression on DCs
analyzed by flow cytometry (left panel), sTRAIL release in culture supernatant, detected by ELISA (middle panel), or susceptibility to recombinant
TRAIL-induced apoptosis, analyzed with the 7-AAD assay (right panel). The mean 6 sd of three independent experiments is shown. (E) Comparative
gene array expression between aNK:iDCHIV and aNK:iDC was performed as described in the Material and Methods section. The expression profiles are
shown for proapoptotic and antiapoptotic genes.
doi:10.1371/journal.ppat.1000862.g004
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PLoS Pathogens | www.plospathogens.org 9 April 2010 | Volume 6 | Issue 4 | e1000862Figure 5. Resistance of HIV-infected iDCs to NK killing is associated with increased expression of c-IAP2 and c-FLIP. (A) Upper panel:
analysis by flow cytometry of intracellular expression of c-IAP2 in DCs that were either uninfected or infected with R5-HIV-1BaL and cultured for 24 h
either alone or in the presence of aNK cells. The percentage of c-IAP2
high cells within DCs is indicated. Lower panel: histograms represent the mean
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apoptosis. Inhibition of the apoptotic response to TRAIL in many
cancer cells involves NF-kB activation that upregulates, among
anti-apoptotic molecules, c-FLIP and c-IAP2 [43] [44]. In our
study, the involvement of NF-kB in TRAIL-induced resistance of
DCHIV is suggested by the recent demonstration of the ability of
HMGB1 to increase c-IAP2 expression levels in carcinoma cells by
enhancing NF-kB activity [39], and the requirement for HIV to
promote its replication and prevent host-cell apoptosis by
activating NF-kB [45]. This hypothesis is currently under
investigation.
Thus, from our previous data [16], coupled with the results
presented here, we conclude that certain bidirectional NK-DC
interactions, that normally occur after an inflammatory insult, are
altered after infection of iDCs with HIV-1, resulting in (i) the
abnormal maturation of DCHIV that are impaired in their ability
to secrete IL-12 and IL-18 and to prime Th1 cells [16], (ii)
increased expression of HIV-RNA and HIV-DNA in mature
DCHIV [16], (iii) deficient killing of infected DCs by NK cells due
to HMGB1-dependent upregulation of the anti-apoptotic mole-
cules c-FLIP and c-IAP2 in DCHIV (the present study). The pivotal
role of HMGB1 in NK-DCHIV interaction was highlighted by the
observation that it was responsible for promoting the protection of
DCHIV from NK-dependent cytotoxicity, and also involved in the
triggering of HIV-1 replication in DCHIV [16]. The role of
HMGB1 in HIV disease is currently unknown, though plasma
levels were reported to be elevated in HIV-1-infected patients
compared to healthy donors, with the highest concentrations
found in patients with clinical complications [46]. Moreover,
circulating HMGB1 levels were found correlated with HIV-RNA
plasma viral load (M-L Gougeon et al. unpublished data).
Altogether these observations provide evidence for the crucial
role of NK-DC cross-talk in promoting viral dissemination and
maintaining viability of long-term reservoirs in DC population,
they challenge the question of the in vivo involvement of HMGB1
in the triggering of viral replication and persistence of these
reservoirs, and they suggest that c-FLIP or c-IAP2 molecules may
represent therapeutic targets for the destruction of infected DCs.
Materials and Methods
Isolation and preparation of iDC and NK cells
Peripheral Blood Mononuclear Cells (PBMCs) were separated
from the blood of healthy adult donors on a Ficoll-Hypaque
density gradient. Blood was obtained through the EFS (Etablisse-
ment Franc ¸ais du Sang) in the setting of EFS-Institut Pasteur
Convention. A written informed consent was obtained for each
donor to use the cells for clinical research according to French
laws. Our study was approved by IRB, external (EFS Board) as
required by French law and internal (Biomedical Research
Committee Board, Institut Pasteur) as required by Institut Pasteur.
We isolated CD14
+ monocytes from PBMCs by positive
selection using CD14-specific immunomagnetic beads (Miltenyi
Biotech). To generate iDCs, purified CD14
+ monocytes (purity
.95%) were cultured for 5 days (10
6 cells/ml) in RPMI 1640
medium supplemented with 2mM glutamine, 10% FCS, penicillin
(100 U/ml) and streptomycin (100 mg/ml), in the presence of
10 ng/ml of recombinant human (rhu) GM-CSF and 10 ng/ml
rhuIL- 4 (Peprotech), as described [47]. Culture medium was
replaced every 2 days. CD56
+ NK cells were isolated by negative
selection from PBMCs using the «EasySep NK depletion Kit»
(StemCell Technologies). NK cell fraction (CD3
2CD56
+) was
more than 95% pure, as assessed by flow cytometry (FACScalibur,
BD) using FITC-conjugated anti-CD3 and APC-conjugated anti-
CD56 antibodies. Contamination with myeloid cells, assessed with
FITC-conjugated anti-CD14 antibodies, was consistently less than
1%. Purified NK cells were cultured at 10
6cells/ml for 48 hours
either in the presence of suboptimal concentration of IL-2
(100 ng/ml) (Peprotech) to maintain their viability (referred as
rNK), or were activated by a combination of PHA (10 mg/ml)
(Sigma) and rhuIL-2 (10 mg/ml) (referred as aNK cells), before
launching NK-DC coculture experiments. In experiments analyz-
ing CD107a expression, NK cells were stimulated for 24 h with
PMA (50 ng/ml) (Sigma) and ionomycin (300 ng/ml) (Sigma).
Infection of iDCs with HIV-1
Virus stock was prepared by amplification of R5-HIV-1BaL on
Monocytes-derivMDM. Viral stock was then clarified by centri-
fugation prior to determination of HIV-1 p24 concentration. iDCs
were plated in 96-well culture plates at 200,000 cells/well and
incubated for 24 hours at 37uC in a 5% CO2 atmosphere with
HIV-1 at 1 ng p24/ml. Cells were harvested, washed three times
with media containing 10% FCS and, when indicated, rNK or
aNK cells were added at a NK:DC ratio of 5:1. NK-DC cocultures
lasted 24h, unless otherwise indicated, before analysis of DCs
phenotype, viability, or quantification of viral production. In some
experiments, HIV-1 infected iDCs were incubated alone or with
aNK cells, in the presence of rhu-HMGB1 (1 mg/ml) (R&D
Systems), blocking anti-HMGB1 Abs (10 mg/ml) (Abcam), Glyc-
yrrhizin (10 mg/ml) (Sigma-Aldrich) or Bisindolylmalmeimide III
(25mM) (Alexis Biochemicals). HIV-1 concentration in culture
supernatant was determined with the p24 ELISA kit (Ingen). The
frequency of HIV-1-infected cells was determined by flow
cytometry to detect intracellular p24 molecule. Cells were surface
stained with antibodies specific for CD40 (BD) to target DC and
intracellular stained with p24-specific antibodies (Beckman
Coulter). Stained cells were immediately acquired on a FACSca-
libur and analyzed with FlowJo software.
Phenotypic analyses by flow cytometry
Surface staining of DCs was performed with anti-CD40, -HLA
-DR, -CD83, -CD86, -HLA-E or -DC-SIGN (BD Biosciences),
percentage 6 sd of c-IAP2
high DCs under indicated conditions in four independent experiments. * p=0.02. (B) Confocal microscopy analysis of
uninfected iDCs or DCHIV costained with DAPI and c-IAP2 specific antibodies. (C) Uninfected DCs or DCHIV were transfected with control siRNA or
increasing concentrations (0.1–50 nM) of c-IAP2 specific siRNA that were coupled to beads, as described in the Material and Methods section.
Uncoupled beads were used as toxicity control. Cell death was quantified with the 7-AAD assay. Mean 6 sd values of three independent experiments
are shown. (D) Upper panel: flow cytometry analysis of intracellular expression of c-FLIP in iDC that were either uninfected or HIV-infected and then
cultured alone or in the presence of aNK cells for 24 h. The percentage of c-FLIP
high DCs is indicated. Lower panel: histograms represent the mean
percentage 6 sd of c-FLIP
high DCs from three independent experiments. * p=0.04. (E) iDCs or DCHIV were treated with 25 mMo f
Bisindolylmalmeimide III (Bis III) and then cultured alone or in the presence of aNK cells for 24 h. Survival of DCs was quantified by flow cytometry
(7-AAD assay) on gated CD56
neg cells. The mean 6 sd of three independent experiments is shown. * p,0.05. (F) iDCs or DCHIV were transfected with
control siRNA or increasing concentrations (0.1–50 nM) of c-FLIP specific siRNA coupled to beads, as described in Material and Methods section.
Uncoupled beads were used as toxicity control. Cell death was quantified with the 7-AAD assay. Mean values 6 sd of three independent experiments
are shown.
doi:10.1371/journal.ppat.1000862.g005
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PLoS Pathogens | www.plospathogens.org 11 April 2010 | Volume 6 | Issue 4 | e1000862Figure 6. c-IAP-2 and c-FLIP upregulation in HIV-infected iDCs is triggered by HMGB1. (A) Detection of HMGB1, quantified by ELISA, in 24 h
cell-free culture supernatants from iDCs, DCHIV (left histogram) or from cocultures of aNK:iDCs or aNK:DCHIV (right histogram). (B) Immunofluorescence
analysis of intracellular HMGB1 expression in aNK-DC conjugates, iDCs being either uninfected (upper panel) or HIV-infected (lower panel). DCs werec o -
stained with CD40 specific antibodies. HMGB1 is detected both in aNK cells and DCs, whether infected or not. Pictures from one representative
experiment outof three conductedwith different primary cell preparations areshown. (C) iDCs or DCHIV were cultured eitheralone or in the presence of
aNKcells for 24 h. Blocking anti-HMGB1antibodies (10 mg/ml),or glycyrrhizin (10 mg/ml), were addedat coculture initiation.Cell death wasquantified in
DCs with the 7-AAD assay on gated CD56
neg cells. The mean 6 sd of three independent experiments is shown. * p,0.05. (D) iDCs were cultured either
alone,in thepresenceof recombinantHMGB1(10 mg/ml),or with aNKcells.Insome NK-DCcocultures,blocking anti-HMGB1 antibodies (10 mg/ml) were
added. Intra-cellular expression of c-IAP2 in DCs was then analyzed by flow cytometry. Histograms are representative of one out of three independent
experiments. (E) HIV-infected DCs were cocultured with aNK cells in the absence or presence of blocking anti-HMGB1 antibodies (10 mg/ml). Intra-
cellular expression of c-FLIP in DCs was analyzed by flow cytometry. The percentage of c-FLIP
high DCs, gated as CD56
neg cells, is indicated. Dot plots are
representative of one out of three independent experiments. (F) iDCs were cultured either alone, in the presence of rHMGB1, or cocultured with aNK
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APC. Surface staining of NK cells was performed with anti-
mTRAIL (e-Bioscience), -CD56 or -CD107a (BD) mAbs conju-
gated to PE or APC. Cells were stained for 30 minutes at 4uC,
washed twice in PBS/BSA/NaN3 (0.5% BSA, 0.01% NaN3), fixed
with 1% PFA, acquired on a FACScalibur and analyzed with
FlowJo software. Populations of interest were selected by gating
according to FSC/SSC parameters, then targeting DCs as CD56
2
cells and NK cells as CD56
+ cells. For intracellular staining, cells
were fixed with 4% PFA, permeabilized using 0.5% BSA, 0.01%
NaN3, 0.5% Saponin buffer, stained for 20 minutes at room
temperature with FITC-labeled anti-perforin mAbs (BD), PE-
conjugated anti-p24 mAbs (Beckman Coulter), PE-conjugated
anti-active caspase-3 Abs (BD), unconjugated rabbit anti-human c-
IAP2 polyclonal antibody (clone H-85, Santa Cruz Biotechnology)
or c-FLIP antibodies (Santa Cruz biotechnology). For indirect
staining, donkey anti-rabbit PE-conjugated secondary antibodies
(Abcam) were used. Samples were acquired on a FACSCalibur
and analyzed with FlowJo software.
Confocal microscopy
Cells were stained with anti-CD40 mAbs (BD), anti-HMGB1
(Abcam) or anti-c-IAP2 unconjugated rabbit polyclonal antibodies
(clone H-85, Santa Cruz Biotechnology). Goat anti-rabbit Cy5-
conjugated secondary antibodies (Abcam) were used. Cells were
washed in PBS, fixed on poly-L-lysine coated slides (Kindler,
Freiburg, Germany), and mounted in an anti-fade DAPI
Fluoromount-G (Southern Biotech). Slides were observed using a
Zeiss Axiovert 200M Perkin-Elmer Spinning Disk equipped with a
Hamamatsu ORCA II ER camera.
NK-DC coculture experiments and apoptosis
measurement
rNK or aNK cells were cocultured during 24h with uninfected
or HIV-infected iDCs at different NK:DC ratios: 1:5 (2610
5
NK+10
6 DCs/ml), 1:1 (2610
5 NK+2610
5 DC/ml) and 5:1
(1610
6 NK+2610
5 DC). In some experiments, mature DCs (DC0)
were used as controls. DC maturation was induced by 48h
stimulation of iDCs (10
6/ml) with 10 mg/ml LPS (E. Coli serotype
026-B6, Sigma-Aldrich). DC survival was determined with the 7-
AAD assay, as described previously [25]. Briefly, cultured cells
were stained with 20 mg/mL nuclear dye 7-amino-actinomycin D
(7-AAD; Sigma-Aldrich) for 30 minutes at 4uC, and co-stained
with CD56-specific antibody (BD). Surviving DCs were identified
as CD56
2 7-AAD
2 FSC
high cells. When phenotypic character-
ization of DCs was performed in NK-DC cocultures, NK cells
were always excluded from the FACS analysis through their
staining with CD56-specific antibodies.
In some experiments, iDCs were incubated in the presence of
rhuTRAIL (1–1000 ng/ml), (Alexis Biochemicals) or neutralizing
antibodies i.e. anti-TRAIL (1 mg/ml), anti-DR4 (250 ng/ml)
(R&D) or anti-Fas ligand (250 ng/ml). Concanamycin A (Alexis
Biochemicals) was used at 100 nM for blocking perforin-mediated
cytotoxicity in cocultures. Cell free culture supernatants were
tested for soluble TRAIL and HMGB1 levels using ELISA kit
from Diaclone, and Shino-test ELISA kit (IBL), respectively.
Silencing experiments
siRNAs against c-IAP2, c-FLIP and control FITC-labeled
siRNA were purchased from SantaCruz technologies. iDCs or
HIV-infected DCs were seeded at 3610
4 cells/ml in 96-well
plates. Gene-specific siRNAs and the control siRNA (0.1–50nM)
were added to media containing Polymag magnetofection beads (OZ
Biosciences) and incubated 20 minutes at room temperature. Cells
were transfected either with Polymag beads alone, control FITC-
labeled siRNA, c-IAP2 siRNA or with c-FLIP siRNA in a strong
magnetic field (Magnetic plate, OZ Biosciences) for 20 minutes at
37uC, 5% CO2. iDCs were kept in culture in complete medium for
24h before measuring cell death.
Microarray experiments
Total RNA was isolated from cocultures of aNK:iDC or
aNK:DCHIV, and microarray experiments were performed by
Miltenyi Biotech. Cells were centrifuged at 300g and resuspended in
1 ml Lysis/Binding Buffer. Lysate was sheared through a 21G
needle and cleared using a LysateClear Column. Fifty microliter
Oligo(dT) MicroBeads were added to the lysate and mRNA fixed
and purified on a micro column. mRNA was transcribed to labeled
cDNA using the thermo MACS Separator (Miltenyi Biotech) in a
60 min, 42uC in-column incubation with cDNA labeling mix and
1 ml Cy3-dCTP or Cy5-dCTP (1 mM, GE Healthcare). Labeled
cDNA/mRNA hybrids were washed and RNase H digested in a
5m i n ,4 2 uC in-column incubation. cDNA was eluted with 50 ml
cDNA Elution Buffer. PIQOR Microarray Immunology, human,
sense (Miltenyi Biotech) hybridization was performed according to
the manufacturer’s instructions using an automized hybridization
machine (a-Hyb, Miltenyi Biotech). Microarrays were blow-dried
and scanned with the ScanArray Lite (GSI Lumonics) and the
Agilent DNA-Microarray Scanner. Signal processing and quantifi-
cation was conducted with ImaGene software version 5.0 (BioDis-
covery). Local background was subtracted from the signal to obtain
the net signal intensity and the ratio of Cy5/Cy3. Subsequently, the
mean of the ratios of four corresponding spots representing the same
cDNA was computed. Cluster analysis of pro-apoptotic and anti-
apoptotic gene expression was performed by Miltenyi Bioinformatic
services. Pearson correlation coefficient analysis was performed with
the unfiltered ratio 2bkg dataset logarithmized to the basis of two.
One and two dimensional average linkage hierarchical clustering
using Euclidean distance as well as statistical analysis of microarrays
(SAM)4 was performed with TIGR MeV version TM4 setting the
percentage cutoff filter to 30%.
Live videomicroscopy
aNK cells were added to iDCs at aNK:iDC ratio of 5:1. Cells
were centrifuged and the pellet incubated for 15 minutes at 37uCi n
a5 %C O 2 atmosphere to favor cell contacts. The pellet was then
reconstituted in complete culture mediumand cells were seeded at a
concentration of 250 000 cells/ ml in a 35 mm microdish (Ibidi,
France). The culture was observed in bright field using an inverted
microscope Zeiss Axiovert 200M. Cells were maintained in a 37uC,
5% CO2 chamber while videos were recorded.
Stastistical analyses
Statistical analyses were made with the non-parametric Mann-
Whitney test. The P value of significant differences is reported.
Plotted data represent mean 6 standard deviation (s.d.).
Supporting Information
Figure S1 CFSE-stained aNK cells induce apoptosis of imma-
ture DCs in aNK-DC cocultures but do not die. (A) CD56
+ NK
cells in the absence or presence of rHMGB1 (10 mg/ml) during 24 h. Intra-cellular expression of c-FLIP in DCs (gated as CD56
neg cells) was analyzed by
flow cytometry. Histograms are representative of one out of three independent experiments.
doi:10.1371/journal.ppat.1000862.g006
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cultured for 24 h either alone or in the presence of iDCs generated
from purified CD14
+ monocytes in the presence of IL-4 and GM-
CSF (NK:DC ratio 5:1). The survival of CD3
negCD56
+ cells was
determined by flow cytometry with the 7-AAD assay. Apoptotic
NK cells were identified as CD3
neg CD56
+ 7-AAD
+ cells. aNK
cells cocultured with iDCs are not induced to die. Dot plots are
representative of three independent experiments. (B) aNK cells
and iDCs were cultured either separately or co-cultured at 5:1
aNK:DC ratio during 24 h. aNK cells were stained with CFSE
prior to their culture in order to further identify them by FACS
analysis. The death of DCs, gated as CFSE
neg cells, was
determined by flow cytometry combining FSC parameter and 7-
AAD staining. Three populations could be identified: 7-AAD
+
cells corresponding to apoptotic cells, 7-AAD
neg FSC
low corre-
sponding to apoptotic bodies, and 7-AAD
neg FSC
high correspond-
ing to living cells. Comparison of aNK:iDC panel with iDCs panel
shows an increase in apoptotic cells and apoptotic bodies in DCs
(CFSE
neg) when cocultured with aNK cells. These dot plots are
representative of at least 3 experiments.
Found at: doi:10.1371/journal.ppat.1000862.s001 (3.59 MB TIF)
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